Resistance to epithelial growth factor receptor tyrosine kinase inhibitors in a patient with transformation from lung adenocarcinoma to small cell lung cancer: A case report
Liying Fang(Huashan Hospital), Shengqing Li(Qinghai University)
Cited by 17
Related Papers
Crosstalk between the Akt/mTORC1 and NF-κB signaling pathways promotes hypoxia-induced pulmonary hypertension by increasing DPP4 expression in PASMCs
|Acta Pharmacologica Sinica|2019|75
TOPK promotes lung cancer resistance to EGFR tyrosine kinase inhibitors by phosphorylating and activating c-Jun
|Oncotarget|2016|46
The emerging role of dipeptidyl-peptidase-4 as a therapeutic target in lung disease
|Expert Opinion on Therapeutic Targets|2020|40
PTPL1 suppresses lung cancer cell migration via inhibiting TGF-β1-induced activation of p38 MAPK and Smad 2/3 pathways and EMT
|Acta Pharmacologica Sinica|2021|26
Protein tyrosine phosphatase L1 represses endothelial-mesenchymal transition by inhibiting IL-1β/NF-κB/Snail signaling
|Acta Pharmacologica Sinica|2020|19